Indeed, Mcl-1 upregulation in response to proteasome inhibitors has been regarded as a major factor to prevent apoptotic cell death in cancer cells, and its targeted downregulation or pharmacological inhibition enhances the cell death induced by proteasome inhibitors [82–84]. This evidence concerns the gene MCL1 and cancer.